Australian Regenerative Medicine Firm ‘Lands a Great Partner in China’

Source: Streetwise Reports   07/22/2018 A Maxim Group report reviewed the deal between the two companies. In a July 18, 2018, research note, analyst Jason McCarthy reported that Maxim Group raised its price target on Buy-rated [...]
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.